title: Exenatide: a new promising antidiabetic agent.
abstract: Exenatide is a unique agent which can effectively control blood glucose levels in type 2 diabetes mellitus without producing dangerous adverse effects. In addition, it can lower body weight which is very essential for the treatment of obese type 2 diabetes mellitus patients. Since it can delay the destruction of islet beta-cells, type 2 diabetes mellitus patients are not rapidly converted to type 1 diabetes mellitus and ultimately appearance of complications of the disease is halted or delayed. Its long-acting-release formula, which would be used once per week, simultaneously retaining all the properties of twice-daily subcutaneous administration, is undergoing clinical trial. This drug is considered as an adjunct to metformin/sulfonylureas/insulin.
authors.affiliation: Kanak Manjari Institute of Pharmaceutical Sciences, Chhend, Rourkela-769 015, India.
authors.forename: C K
authors.initials: CK
authors.lastname: Chakraborti